Pancreatic enzymes and cancer

2^nd World Congress on Breast Cancer

September 19-21, 2016 Phoenix, USA

Linda L Isaacs

Nutritional Research and Educational Foundation, USA

Scientific Tracks Abstracts: J Cancer Sci Ther

Abstract :

Pancreatic proteolytic enzymes have been used in the management of cancer for more than 100 years. The theoretical rationale was described by the embryologist Dr. John Beard, who noted the similarity of cancer cells to the trophoblast and who may have been the first researcher to speculate that cancer originates from stem cells. Various other practitioners have used pancreatic enzymes against cancer since Dr. Beard�s time. In her lecture, Dr. Isaacs will review this history, and describe case reports of breast cancer patients successfully treated with enzymes.

Biography :

Linda L Isaacs received her Medical degree from Vanderbilt University School of Medicine and is certified by the American Board of Internal Medicine. She has written papers published in the peer-reviewed journals Nutrition and Cancer and Alternative Therapies in Health and Medicine, and has served as a reviewer for Alternative Therapies in Health and Medicine. She is the co-author, with Dr. Nicholas Gonzalez, of the book The Trophoblast and the Origins of Cancer.

Email: lindaisaacsmd@hushmail.com